CLINICAL RESEARCH
Dr. Landon has been a pioneer in medical research in many areas. His projects span fields of clinical drug trials to innovative devices and new break through methodologies. To review Dr. Landon's past research publications, visit the following weblink:
https://www.researchgate.net/profile/Chris_Landon2/contributions
Research interests:
Behavioral health
Cancer
Care transitions
Children’s health issues
Comparative effectiveness research on improving healthcare systems and/or patient experiences
Coordination of care for complex patients
Depression and other mental health disorders
Developmental delays, attention deficit hyperactivity disorder, autism
Diabetes (Type 1 or 2)
Functional limitations and physical disabilities
Health literacy
Immunizations
Obesity, physical activity, and/or diet and nutrition
Pulmonary disease/asthma
Current Studies:
AbbVie Inc.
This study aims to compare pancrelipase delayed-release modernized process to pancrepilase DR (Creon) in dietary fat absorption in CF patients with EPI. EPI is a condition where the pancreas organ does not deliver enough digestive enzymes to the small intestine to break down food you eat.
Insmed Inc.
This double-blind study aims to evaluate the efficacy, safety, and tolerability of the study drug, Brensocatib, as treatment for individuals with non-cystic fibrosis bronchiectasis.
Vironix/Iterex
This study aims to test a phone application that is designed to guide and assist individuals with COPD and/or asthma on appropriate actions to take based on the symptoms and vital signs they input into the app.
CareCOPD
This NIH (National Institutes of Health) study, for patients with COPD, uses two new FDA-approved devices to measure lung health and medication usage. Its aims are to investigate if we can learn about lung health by studying the patterns and trends in the daily lung obstruction data. Data will help scientists and physicians understand how lungs change over time for COPD patients and what the best care interventions would be.
CHLA CIAPM (CA Initiative to Advance Precision Medicine)
The goal of this research program is to improve the power of early screening by combining the use of a questionnaire to identify infants exposed to adverse childhood experiences (ACEs) by using innovative laboratory biomeasures, monitoring maternal well-being and challenges, and implementing developmental assessments that independently identify disruptions in metabolic health, a specific consequence of toxic stress.
Hill-Rom Company Inc.
The purpose of this research study is to determine the effectiveness of The Volara® System in treating breathing problems in participants with neuromuscular disease, such as spinal cord injury, muscular dystrophy, or Multiple Sclerosis. The Volara® System is a device that is designed to assist patients that require regular airway clearance and/or lung expansion therapy due to respiratory disease.
